American International Group’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-18,378
| Closed | -$380K | – | 924 |
|
|
2024
Q1 | $380K | Buy |
18,378
+5,101
| +38% | +$105K | ﹤0.01% | 1791 |
|
|
2023
Q4 | $307K | Buy |
13,277
+206
| +2% | +$4.76K | ﹤0.01% | 1927 |
|
|
2023
Q3 | $104K | Buy |
13,071
+464
| +4% | +$3.71K | ﹤0.01% | 2489 |
|
|
2023
Q2 | $110K | Buy |
12,607
+17
| +0.1% | +$148 | ﹤0.01% | 2517 |
|
|
2023
Q1 | $37K | Buy |
12,590
+251
| +2% | +$738 | ﹤0.01% | 2787 |
|
|
2022
Q4 | $43.2K | Sell |
12,339
-45
| -0.4% | -$158 | ﹤0.01% | 2788 |
|
|
2022
Q3 | $98K | Buy |
12,384
+175
| +1% | +$1.39K | ﹤0.01% | 2564 |
|
|
2022
Q2 | $96K | Sell |
12,209
-161
| -1% | -$1.27K | ﹤0.01% | 2619 |
|
|
2022
Q1 | $150K | Buy |
12,370
+1,142
| +10% | +$13.8K | ﹤0.01% | 2413 |
|
|
2021
Q4 | $137K | Sell |
11,228
-336
| -3% | -$4.1K | ﹤0.01% | 2578 |
|
|
2021
Q3 | $120K | Sell |
11,564
-275
| -2% | -$2.85K | ﹤0.01% | 2714 |
|
|
2021
Q2 | $106 | Buy |
+11,839
| New | +$106 | ﹤0.01% | 2859 |
|
|
2020
Q2 | – | Sell |
-3,734
| Closed | -$38K | – | 3123 |
|
|
2020
Q1 | $38K | Sell |
3,734
-216
| -5% | -$2.2K | ﹤0.01% | 2784 |
|
|
2019
Q4 | $61K | Buy |
3,950
+41
| +1% | +$633 | ﹤0.01% | 2828 |
|
|
2019
Q3 | $71K | Sell |
3,909
-27
| -0.7% | -$490 | ﹤0.01% | 2775 |
|
|
2019
Q2 | $65K | Buy |
+3,936
| New | +$65K | ﹤0.01% | 2877 |
|